Intravenous Immune Globulin (IVIG) to Prevent Neonatal Infection

ClinicalTrials.gov ID: NCT01203345

Public ClinicalTrials.gov record NCT01203345. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Jul 21, 2026, 11:21 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Randomized Clinical Trial of Intravenous Immune Globulin (IVIG) to Prevent Neonatal Infection in Very-Low-Birth-Weight Infants

Study identification

NCT ID: NCT01203345
Recruitment status: Completed
Study type: Interventional
Phase: Phase 2, Phase 3
Lead sponsor: NICHD Neonatal Research Network; Network
Enrollment: 2,416 participants

Conditions and interventions

Conditions

Interventions

IVIG Drug
Placebo Drug

Drug

Eligibility (public fields only)

Age range: Up to 72 Hours
Sex: All
Healthy volunteers: Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Dec 31, 1987
Primary completion: Feb 28, 1991
Completion: Feb 28, 1991
Last update posted: Mar 21, 2019

1988 – 1991

United States locations

U.S. sites: 8
U.S. states: 8
U.S. cities: 8

Facility	City	State	ZIP	Site status
University of Alabama at Birmingham	Birmingham	Alabama	35233	—
George Washington University	Washington D.C.	District of Columbia	20052	—
University of Miami	Miami	Florida	33136	—
Wayne State University	Detroit	Michigan	48201	—
Case Western Reserve University, Rainbow Babies and Children's Hospital	Cleveland	Ohio	44106	—
University of Tennessee	Memphis	Tennessee	38163	—
University of Texas Southwestern Medical Center at Dallas	Dallas	Texas	75235	—
University of Vermont	Burlington	Vermont	05405	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT01203345, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Mar 21, 2019 · Synced Jul 21, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01203345 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →